Harwin Steven F, Issa Kimona, Naziri Qais, Pivec Robert, Johnson Aaron J, Mont Michael A
Department of Orthopaedic Surgery, Beth Israel Medical Center, New York, New York, USA.
J Knee Surg. 2013 Jun;26(3):151-4. doi: 10.1055/s-0032-1324812. Epub 2012 Sep 21.
Revision total knee arthroplasty (TKA) can be quite challenging in Jehovah's Witness patients because blood transfusion is often needed, however, these patients do not accept allogeneic or autologous blood due to religious convictions. We reported our clinical experiences with a special blood management protocol for Jehovah's Witnesses who underwent a revision TKA. There were 12 self-reported Jehovah's Witness patients (12 total knee arthroplasties) who had a mean age of 69 years (range: 55 to 79 years) and who underwent revision TKA between 1998 and 2009. All revision surgeries were due to aseptic component failure. Implant survivorship was 100% over a mean follow-up of 62 months (range: 24 to 120 months). The Knee Society objective and function scores improved to a mean of 83 and 82 points, respectively. The authors believe that the use of this blood management protocol was responsible for the excellent clinical outcomes.
翻修全膝关节置换术(TKA)对于耶和华见证会的患者而言颇具挑战性,因为通常需要输血,然而,由于宗教信仰,这些患者不接受异体或自体输血。我们报告了针对接受翻修TKA的耶和华见证会患者采用特殊血液管理方案的临床经验。有12名自称耶和华见证会的患者(共12例全膝关节置换术),平均年龄69岁(范围:55至79岁),于1998年至2009年间接受了翻修TKA。所有翻修手术均因无菌性假体组件失败。在平均62个月(范围:24至120个月)的随访中,植入物生存率为100%。膝关节协会客观评分和功能评分分别提高到平均83分和82分。作者认为,采用这种血液管理方案是取得优异临床结果的原因。